We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4B
AUM Growth
-$1.11B
Cap. Flow
-$117M
Cap. Flow %
-0.67%
Top 10 Hldgs %
25.42%
Holding
3,045
New
14
Increased
313
Reduced
2,663
Closed
30

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.3M
2
NVDA icon
NVIDIA
NVDA
+$38.8M
3
AAPL icon
Apple
AAPL
+$36.4M
4
WSM icon
Williams-Sonoma
WSM
+$21.8M
5
EXE
Expand Energy Corp
EXE
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Financials 13.87%
3 Consumer Discretionary 10.73%
4 Healthcare 10.45%
5 Industrials 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYTX icon
2876
Kyverna Therapeutics
KYTX
$449M
$24.4K ﹤0.01%
12,624
-187
-1% -$553
LINE
2877
Lineage Inc
LINE
$8.6B
$24.3K ﹤0.01%
415
-13
-3% -$758
TUSK icon
2878
Mammoth Energy Services
TUSK
$149M
$24.3K ﹤0.01%
11,904
-176
-1% -$469
CRVO icon
2879
CervoMed
CRVO
$38.9M
$24.2K ﹤0.01%
2,646
-39
-1% -$149
INZY
2880
DELISTED
Inozyme Pharma
INZY
$23.9K ﹤0.01%
26,301
+236
+0.9% +$327
JSPR icon
2881
Jasper Therapeutics
JSPR
$22M
$23.8K ﹤0.01%
5,546
-82
-1% -$546
RDNW
2882
RideNow Group
RDNW
$220M
$23.7K ﹤0.01%
8,397
-124
-1% -$511
PYXS icon
2883
Pyxis Oncology
PYXS
$268M
$23.7K ﹤0.01%
24,165
-114
-0.5% -$152
IVVD icon
2884
Invivyd
IVVD
$232M
$23.5K ﹤0.01%
38,853
-576
-1% -$517
APLT
2885
DELISTED
Applied Therapeutics
APLT
$23.5K ﹤0.01%
47,972
+174
+0.4% +$102
BLUE
2886
DELISTED
bluebird bio
BLUE
$23.3K ﹤0.01%
4,781
-72
-1% -$433
AFRI icon
2887
Forafric Global
AFRI
$298M
$23.2K ﹤0.01%
2,695
-40
-1% -$373
ABOS icon
2888
Acumen Pharmaceuticals
ABOS
$211M
$22.6K ﹤0.01%
20,550
-305
-1% -$436
ANRO icon
2889
Alto Neuroscience
ANRO
$1.26B
$22.6K ﹤0.01%
10,465
-155
-1% -$555
QRHC icon
2890
Quest Resource Holding
QRHC
$28.9M
$22.4K ﹤0.01%
8,624
-41
-0.5% -$194
HLVX
2891
DELISTED
HilleVax
HLVX
$22.4K ﹤0.01%
15,441
-229
-1% -$423
CLPR
2892
Clipper Realty
CLPR
$52M
$22.4K ﹤0.01%
5,824
-87
-1% -$365
BIOA
2893
BioAge Labs
BIOA
$390M
$22.4K ﹤0.01%
5,945
-87
-1% -$402
VTSI icon
2894
VirTra
VTSI
$33.7M
$22K ﹤0.01%
5,409
-15
-0.3% -$90
AMPX icon
2895
Amprius Technologies
AMPX
$1.38B
$21.6K ﹤0.01%
8,041
+230
+3% +$679
DJT icon
2896
Trump Media & Technology Group
DJT
$2.41B
$21.5K ﹤0.01%
1,100
+46
+4% +$1.29K
LLYVK icon
2897
Liberty Live Group Series C
LLYVK
$8.96B
$21.3K ﹤0.01%
312
-11
-3% -$785
PRPL icon
2898
Purple Innovation
PRPL
$14.2M
$21.1K ﹤0.01%
1,114
-17
-2% -$392
W icon
2899
Wayfair
W
$13.5B
$20.9K ﹤0.01%
653
-9
-1% -$374
MRDN
2900
Meridian Holdings Inc
MRDN
$173M
$20.9K ﹤0.01%
883
+33
+4% +$801

Similar funds

Corebridge Financial's Q1 2025 Portfolio in Review

As of Q1 2025, Corebridge Financial held 3,045 positions worth $17.4B, down 6% from $18.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 1.4%. Corebridge Financial opened 14 new positions and exited 30, leaving the 3,045-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q1 2025 buy was State Street Blackstone Senior Loan ETF: 9,585,037 shares worth $394M.
  • Corebridge Financial added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2025, an estimated $19.5M increase.
  • Corebridge Financial's biggest Q1 2025 reduction was Microsoft, cutting an estimated $39.3M.
  • Corebridge Financial fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $10.6M.
  • Corebridge Financial's ten largest holdings make up 25% of its $17.4B portfolio in Q1 2025.
  • Corebridge Financial opened 14 new positions and closed 30 in Q1 2025.
  • Corebridge Financial's portfolio value fell 6% quarter-over-quarter to $17.4B.

Based on Corebridge Financial's 13F filing for Q1 2025, filed 14 May 2025.